First-in-Human Study of OKI-219 Alone and in Combination with Other Therapies in Patients with Solid Tumors / Breast Cancer

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508435-31-00

Acronym

OKI-219-101

Enrollment

145

Registered

2024-04-18

Start date

2024-08-09

Completion date

Unknown

Last updated

2025-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Breast Cancer, Advanced Solid Tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026